Features to consider for mimicring tissues in orofacial aesthetics with optimal balance technology and non-animal stabilized hyaluronic acid (Restylane (R)): The MIMT concept

Autor(es)

Rogerio, Victor ; Vieira, Marcelo Germani ; Rabelo, Viviane ; Carbone, Ana Claudia ; Machado Filho, Daniel Augusto ; Da Silva, Adriana Mendonca ; Canales, Giancarlo De La Torre

• Tipo de documento: Artigo Científico
• Fonte: JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY; v. 123, n. 4, p. 8-pg., 2022-08-22.

Resumo

Nonsurgical cosmetic treatments have significantly increased over the last decade. Therefore, this study aims to review the features that should be considered in orofacial esthetic procedures, thorough of a proposal of a new concept called the tissue mimicry concept (MIMT concept) and filling techniques. The MIMT concept described in this article comprises knowledge about anatomy of the face and associated structures, under-standing of aging and how this process affects the facial tissues interactions (skin, subcutaneous tissues, muscles, and bones), interpretation of facial analysis, comprehension of dermal fillers characteristics and dis-cernment of the correct filling technique for each region. Based on these variables the MIMT concept pro-poses the implantation of the minimum-effective quantity of acid hyaluronic fillers (HA) with different physical, chemical and rheological properties (complex viscosity and elastic modulus) in the correct layers; in order to optimize their performance resulting in a natural appearance with fewer risks of adverse events. the versatility, acceptable safety profile, biocompatibility and greater patient compliance presented in the Restylane (R) line (by Galderma) should be taken in consideration, since the use of a proper HA is noteworthi-ness. The Non-Animal Stabilized Hyaluronic Acid Tecnology (NASHA (R)) and the Optimal Balance Technology (OBT (R)), which make up this line of fillers, allow us to have very firm to very flexible gels, with different parti-cle sizes, with an optimal concentration of HA and with viscoelastic and biocompatible characteristics according to the region of the treated face. (C) 2021 Elsevier Masson SAS. All rights reserved. (AU)

• Processo FAPESP: 17/21674-0 - Comparação da eficácia da toxina botulínica tipo A em pacientes com dor orofacial crônica refratária, de acordo com diferentes perfis somatosensoriais
• Beneficiário: Giancarlo de La Torre Canales
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado